甲状腺毒症治疗后持续性心房颤动的电复律
Electrical cardioversion for persistent atrial fibrillation after treatment of thyrotoxicosis.
作者信息
Emery P, Staffurth J S
出版信息
Postgrad Med J. 1982 Dec;58(686):746-8. doi: 10.1136/pgmj.58.686.746.
Abstract
A review of 22 patients with atrial fibrillation after the treatment of thyrotoxicosis, who underwent elective electrical cardioversion, showed that only 45% were still in sinus rhythm at 2 years and 36% in the long term (mean 7·4 years). There were no significant differences in factors assessed between those persisting in sinus rhythm and in those who relapsed. A delay in the initial curative treatment of thyrotoxicosis may be a factor in influencing the outcome.
摘要
对22例甲状腺毒症治疗后发生心房颤动且接受择期电复律的患者进行的一项回顾性研究显示，2年后仅有45%的患者仍维持窦性心律，长期（平均7.4年）维持窦性心律的患者比例为36%。在维持窦性心律的患者和复发的患者之间，所评估的因素没有显著差异。甲状腺毒症初始治疗的延迟可能是影响预后的一个因素。
相似文献
1
Electrical cardioversion for persistent atrial fibrillation after treatment of thyrotoxicosis.甲状腺毒症治疗后持续性心房颤动的电复律
Postgrad Med J. 1982 Dec;58(686):746-8. doi: 10.1136/pgmj.58.686.746.
2
Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.甲状腺功能亢进所致持续性心房颤动与非甲状腺功能亢进所致持续性心房颤动患者成功电复律后房颤复发率的比较。
Am J Cardiol. 2009 Feb 15;103(4):540-3. doi: 10.1016/j.amjcard.2008.10.019. Epub 2008 Dec 25.
3
[Clinical considerations in the treatment of atrial fibrillation (in thyrotoxicosis patients)].
Ter Arkh. 1984;56(9):62-6.
4
Management of atrial fibrillation in the post-thyrotoxic state.甲状腺毒症后心房颤动的管理
Am J Med. 1982 Jun;72(6):903-6. doi: 10.1016/0002-9343(82)90850-6.
5
[Late results following cardioversion].
Wien Z Inn Med. 1967;48(7):275-83.
6
Acute right ventricular dysfunction after cardioversion or hyperthyroid cardiomyopathy in an unrecognized thyrotoxicosis patient?
Am J Emerg Med. 2007 Jul;25(6):723-4. doi: 10.1016/j.ajem.2006.11.036.
7
Atrial fibrillation with hyperthyroidism in a 14-year-old male.一名14岁男性患甲状腺功能亢进伴心房颤动。
Pediatr Cardiol. 2006 Nov-Dec;27(6):772-4. doi: 10.1007/s00246-006-1409-x. Epub 2006 Nov 7.
8
Hyperthyroidism and the management of atrial fibrillation.甲状腺功能亢进症与心房颤动的管理
Thyroid. 2002 Jun;12(6):489-93. doi: 10.1089/105072502760143863.
9
[Reversible thyrotoxic cardiomyopathy--report of three cases].[可逆性甲状腺毒症性心肌病——三例报告]
Pol Arch Med Wewn. 2002 Oct;108(4):979-82.
10
Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation.持续性心房颤动患者电复律的最佳时机。
Med Sci Monit. 2010 Oct;16(10):CR464-8.
引用本文的文献
1
Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients.甲状腺功能亢进和甲状腺功能正常患者心房颤动复发的预测因素
Arq Bras Cardiol. 2016 Feb;106(2):84-91. doi: 10.5935/abc.20160013. Epub 2016 Jan 26.
2
Hyperthyroidism in elderly patients with atrial fibrillation and normal thyroid hormone measurements.甲状腺激素测量正常的老年房颤患者中的甲状腺功能亢进症
J R Soc Med. 1987 Feb;80(2):74-6. doi: 10.1177/014107688708000205.
本文引用的文献
1
Atrial fibrillation and arterial embolism in hyperthyroidism.甲状腺功能亢进症中的心房颤动和动脉栓塞
Aust N Z J Med. 1981 Aug;11(4):391-3. doi: 10.1111/j.1445-5994.1981.tb03519.x.
2
Direct current shock therapy of cardiac arrhythmias.心律失常的直流电休克疗法。
Br Heart J. 1966 May;28(3):366-73. doi: 10.1136/hrt.28.3.366.
3
Atrial fibrillation in thyrotoxicosis treated with radioiodine.放射性碘治疗甲状腺毒症所致心房颤动
Postgrad Med J. 1965 Nov;41(481):663-71. doi: 10.1136/pgmj.41.481.663.
4
Long-term results of DC reversion of atrial fibrillation.心房颤动直流电转复的长期结果。
Br Heart J. 1968 Jan;30(1):91-6. doi: 10.1136/hrt.30.1.91.
5
Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation.
Acta Med Scand. 1971 Mar;189(3):161-6. doi: 10.1111/j.0954-6820.1971.tb04358.x.
6
Pathology of atrial fibrillation in man.人类心房颤动的病理学
Br Heart J. 1972 May;34(5):520-5. doi: 10.1136/hrt.34.5.520.
7
Arterial embolism in thyrotoxicosis with atrial fibrillation.甲状腺毒症合并心房颤动时的动脉栓塞
Br Med J. 1977 Sep 10;2(6088):688-90. doi: 10.1136/bmj.2.6088.688.
8
Thyroid heart disease.甲状腺性心脏病
Br Heart J. 1979 Mar;41(3):257-62. doi: 10.1136/hrt.41.3.257.
Zotero 插件